WASHINGTON — When the Food and Drug Administration said Tuesday it would eventually lower the level of tobacco in cigarettes to non-addictive levels, the American Heart Association called it “historic.” Powerful lawmakers applauded the action. The New York Times put the announcement on its front page — writing that the move “would put the United States at the forefront of global antismoking efforts.”
And while lowering nicotine levels in cigarettes would be a massive deal, the FDA this week only took a first, very small step, toward that goal. And it has even taken that small step before, though to far less fanfare.
This blog is for information purposes only. The content is not intended as medical advice, diagnosis, or treatment. Should you have a medical or dermatological problem, please consult with your physician. None of the information or recommendations on this website should be interpreted as medical advice.
All product reviews, recommendations, and references are based on the author’s personal experience and impressions using the products. All views and opinions are the author’s own.
This blog post may contain affiliate links. An affiliate link means we may earn a commission if you click on a link and make a purchase, without any extra cost to you.
Please see our Disclaimer for more information.